1. Home
  2. LSAK vs XOMA Comparison

LSAK vs XOMA Comparison

Compare LSAK & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSAK
  • XOMA
  • Stock Information
  • Founded
  • LSAK 1997
  • XOMA 1981
  • Country
  • LSAK South Africa
  • XOMA United States
  • Employees
  • LSAK N/A
  • XOMA N/A
  • Industry
  • LSAK Investment Bankers/Brokers/Service
  • XOMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • LSAK Finance
  • XOMA Health Care
  • Exchange
  • LSAK Nasdaq
  • XOMA Nasdaq
  • Market Cap
  • LSAK 344.5M
  • XOMA 330.2M
  • IPO Year
  • LSAK N/A
  • XOMA N/A
  • Fundamental
  • Price
  • LSAK $4.74
  • XOMA $32.47
  • Analyst Decision
  • LSAK
  • XOMA Strong Buy
  • Analyst Count
  • LSAK 0
  • XOMA 2
  • Target Price
  • LSAK N/A
  • XOMA $69.50
  • AVG Volume (30 Days)
  • LSAK 18.6K
  • XOMA 57.0K
  • Earning Date
  • LSAK 09-10-2025
  • XOMA 08-13-2025
  • Dividend Yield
  • LSAK N/A
  • XOMA N/A
  • EPS Growth
  • LSAK N/A
  • XOMA N/A
  • EPS
  • LSAK N/A
  • XOMA N/A
  • Revenue
  • LSAK $574,080,000.00
  • XOMA $44,952,000.00
  • Revenue This Year
  • LSAK $1.06
  • XOMA $82.30
  • Revenue Next Year
  • LSAK $13.32
  • XOMA $12.59
  • P/E Ratio
  • LSAK N/A
  • XOMA N/A
  • Revenue Growth
  • LSAK 4.13
  • XOMA 194.98
  • 52 Week Low
  • LSAK $3.39
  • XOMA $18.35
  • 52 Week High
  • LSAK $5.60
  • XOMA $35.23
  • Technical
  • Relative Strength Index (RSI)
  • LSAK 51.59
  • XOMA 61.79
  • Support Level
  • LSAK $4.60
  • XOMA $32.60
  • Resistance Level
  • LSAK $4.76
  • XOMA $34.60
  • Average True Range (ATR)
  • LSAK 0.11
  • XOMA 1.82
  • MACD
  • LSAK -0.01
  • XOMA 0.09
  • Stochastic Oscillator
  • LSAK 36.73
  • XOMA 66.75

About LSAK Lesaka Technologies Inc.

Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: